The Pfizer IIT Delhi Innovation and IP Program (PIDIIP) envisages a unique partnership model is designed to provide funding, resources, expertise and infrastructure to propel India's healthcare innovations from idea to intellectual property (IP).
The program envisages active support for incubation and intellectual property creation.
There are two components of the Pfizer IIT Delhi Innovation & IP Program (PIDIIP):
For innovators seeking comprehensive support to translate their healthcare ideas into new business opportunities, the Program provides:
-Incubation at IIT Delhi's incubators for a period of up to two years.
-Funding of up to Rs 50 lakhs for each innovator/start-up to take ideas through proof of concept to IP
-Mentoring support from IIT Delhi's faculty and FITT nominated experts.
-IP search and filing services.
-Guidance from Pfizer's experts.
For innovators who already have a proof of principle/concept and are only looking for IP related support, the program provides:
-Access to IP counseling services at FITT.
-Funding support of up to Rs. 3 lakh to cover patenting expenses.
The call for proposals is currently open till May 30.
Visit www.pidiip-fitt-iitd.in for further details.
.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
